Isentress - Merck.com
... The safety of ISENTRESS was evaluated in HIV-infected treatment-naïve subjects in 2 Phase III studies: STARTMRK evaluated ISENTRESS 400 mg twice daily versus efavirenz, both in combination with emtricitabine (+) tenofovir disoproxil fumarate (TDF), and ONCEMRK evaluated ISENTRESS HD 1200 mg (2 x 600 ...
... The safety of ISENTRESS was evaluated in HIV-infected treatment-naïve subjects in 2 Phase III studies: STARTMRK evaluated ISENTRESS 400 mg twice daily versus efavirenz, both in combination with emtricitabine (+) tenofovir disoproxil fumarate (TDF), and ONCEMRK evaluated ISENTRESS HD 1200 mg (2 x 600 ...
REFERENCE GUIDE FOR THE PHARMACY LICENSING EXAM
... are commonly reported side effects of the drug. 3). Concomitant use of Zonisamide (Zonegran), a carbonic anhydrase inhibitor, with any other carbonic anhydrase inhibitor (e.g., topiramate, acetazolamide or dichlorphenamide), may increase the severity of metabolic acidosis and may also increase the r ...
... are commonly reported side effects of the drug. 3). Concomitant use of Zonisamide (Zonegran), a carbonic anhydrase inhibitor, with any other carbonic anhydrase inhibitor (e.g., topiramate, acetazolamide or dichlorphenamide), may increase the severity of metabolic acidosis and may also increase the r ...
Dynacin Prescribing Information
... renal impairment exists, even usual oral or parenteral doses may lead to excessive systemic accumulations of the drug and possible liver toxicity. Under such conditions, lower than usual total doses are indicated, and if therapy is prolonged, serum level determinations of the drug may be advisable. ...
... renal impairment exists, even usual oral or parenteral doses may lead to excessive systemic accumulations of the drug and possible liver toxicity. Under such conditions, lower than usual total doses are indicated, and if therapy is prolonged, serum level determinations of the drug may be advisable. ...
capecitabine - Medicines and Healthcare products Regulatory Agency
... mg film-coated tablets (PL 42244/0007-0008; UK/H/6096/001-02/DC). It explains how Capecitabine Reliance 150 mg and 500 mg film-coated tablets were assessed and their authorisation recommended, as well as their conditions of use. It is not intended to provide practical advice on how to use Capecitabi ...
... mg film-coated tablets (PL 42244/0007-0008; UK/H/6096/001-02/DC). It explains how Capecitabine Reliance 150 mg and 500 mg film-coated tablets were assessed and their authorisation recommended, as well as their conditions of use. It is not intended to provide practical advice on how to use Capecitabi ...
Hard gelatin capsules today – and tomorrow
... acetylsalicylic acid is in contact with the surface of the particles of all the other excipients. As the humidity in the environment will always lead to absorption of moisture on the surface, the particles will be surrounded by a mono-layer of a saturated solution. To optimize product stability, the ...
... acetylsalicylic acid is in contact with the surface of the particles of all the other excipients. As the humidity in the environment will always lead to absorption of moisture on the surface, the particles will be surrounded by a mono-layer of a saturated solution. To optimize product stability, the ...
Using METHOCEL Cellulose Ethers for Controlled
... approval. In addition, METHOCEL products are supported by Dow’s extensive experience in pharmaceutical applications and a broad body of technical knowledge. We invite you to use this handbook while you develop new hydrophilic matrix drug formulations or when improvements in existing formulations are ...
... approval. In addition, METHOCEL products are supported by Dow’s extensive experience in pharmaceutical applications and a broad body of technical knowledge. We invite you to use this handbook while you develop new hydrophilic matrix drug formulations or when improvements in existing formulations are ...
Hycodan® (hydrocodone bitartrate) - Bristol
... The use of hydrocodone is contraindicated in patients below the age of 6 years. In young children, the respiratory centre is especially susceptible to the depressant action of narcotic cough suppressants. The use of hydrocodone bitartrate in children less than 6 years of age has been associated with ...
... The use of hydrocodone is contraindicated in patients below the age of 6 years. In young children, the respiratory centre is especially susceptible to the depressant action of narcotic cough suppressants. The use of hydrocodone bitartrate in children less than 6 years of age has been associated with ...
Prednisone Suspension 5mg/mL
... predetermined time points up to 90 days. A validated stability-indicating highperformance liquid chromatography method was developed. Beyond-use date was evaluated by statistical analysis of the overall degradation trend. Prednisone was stable for at least 90 days at 25°C. No changes in organoleptic ...
... predetermined time points up to 90 days. A validated stability-indicating highperformance liquid chromatography method was developed. Beyond-use date was evaluated by statistical analysis of the overall degradation trend. Prednisone was stable for at least 90 days at 25°C. No changes in organoleptic ...
Pharmacy Newsletter - Gold Coast Health Plan
... In addition to the preventive measures that a patient and his/her family can take, medication management is the primary means of treating this disease. For GCHP, anti-asthmatic medications are sixth among the prescriptions filled in all therapeutic classes. This is good, but we could do better. The ...
... In addition to the preventive measures that a patient and his/her family can take, medication management is the primary means of treating this disease. For GCHP, anti-asthmatic medications are sixth among the prescriptions filled in all therapeutic classes. This is good, but we could do better. The ...
03/11/11 - Magellan Rx Management
... indicated as second-line therapy for short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in patients who have failed to respond adequately to other topical prescription treatments for atopic dermatitis or when those treatments are not advisable. Point-of-sale appr ...
... indicated as second-line therapy for short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in patients who have failed to respond adequately to other topical prescription treatments for atopic dermatitis or when those treatments are not advisable. Point-of-sale appr ...
Managing Feline Hyperthyroidism
... cats were reported with lethargy, vomiting, anorexia, and bloody diarrhea; one cat also had pallor. In a second foreign field study with 78 cats using a starting dose of 2.5 mg twice daily, 4 cats were withdrawn due to suspected adverse reactions to FELIMAZOLE Coated Tablets including anemia, cholan ...
... cats were reported with lethargy, vomiting, anorexia, and bloody diarrhea; one cat also had pallor. In a second foreign field study with 78 cats using a starting dose of 2.5 mg twice daily, 4 cats were withdrawn due to suspected adverse reactions to FELIMAZOLE Coated Tablets including anemia, cholan ...
International Journal of Pharmacy
... The two proposed methods based on the spectrophotometry were developed and validated as per ICH guidelines. The standard deviation and % RSD calculated for the proposed methods are low, indicating high degree of precision of the methods. The results of the recovery studies performed show the high de ...
... The two proposed methods based on the spectrophotometry were developed and validated as per ICH guidelines. The standard deviation and % RSD calculated for the proposed methods are low, indicating high degree of precision of the methods. The results of the recovery studies performed show the high de ...
EVALUATION OF TAMARIND SEED POLYSACCHARIDE AS ABIODEGRADABLE CARRIER FOR COLON SPECIFIC DRUG DELIVERY
... containing different concentrations (30% w/w to 70% w/w) of TSP using Ibuprofen as a model drug. The matrix tablets were evaluated for different quality control tests, content uniformity and invitro drug release study. Drug release profile of prepared tablets ...
... containing different concentrations (30% w/w to 70% w/w) of TSP using Ibuprofen as a model drug. The matrix tablets were evaluated for different quality control tests, content uniformity and invitro drug release study. Drug release profile of prepared tablets ...
EXTEMPORANEOUS PREPARATION OF PAEDIATRIC ORAL
... The use of extemporaneous preparations can be considered as unlicensed drug use and these raise concerns about quality, stability, bioavailability, efficacy and safety. Currently, there are no appropriate and comprehensive published standards, and thus decisions in different steps of preparation pro ...
... The use of extemporaneous preparations can be considered as unlicensed drug use and these raise concerns about quality, stability, bioavailability, efficacy and safety. Currently, there are no appropriate and comprehensive published standards, and thus decisions in different steps of preparation pro ...
Carbinoxamine Maleate
... neck obstruction, pyloroduodenal obstruction. PRECAUTIONS: General: As many other antihistamines, carbinoxamine maleate has an atropine-like action and, therefore, should be used with caution in patients with: increased intraocular pressure, hyperthyroidism, cardiovascular disease, hypertension. Ant ...
... neck obstruction, pyloroduodenal obstruction. PRECAUTIONS: General: As many other antihistamines, carbinoxamine maleate has an atropine-like action and, therefore, should be used with caution in patients with: increased intraocular pressure, hyperthyroidism, cardiovascular disease, hypertension. Ant ...
Development, Estimation and Validation of Aripiprazole
... Abstract: A new, simple, specific, sensitive, rapid, accurate and precise RP-HPLC method was developed for the estimation of Aripiprazole in bulk and pharmaceutical formulations. Aripiprazole was chromatographed on a INERTSIL C18 column (250x4.6mm I.D., particle size 5 μm) in a mobile phase consisti ...
... Abstract: A new, simple, specific, sensitive, rapid, accurate and precise RP-HPLC method was developed for the estimation of Aripiprazole in bulk and pharmaceutical formulations. Aripiprazole was chromatographed on a INERTSIL C18 column (250x4.6mm I.D., particle size 5 μm) in a mobile phase consisti ...
ceftin tablets and oral suspension
... overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxinproducing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be co ...
... overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxinproducing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be co ...
Filling two-piece hard gelatin capsules with liquids
... variability in delivering the active pharmaceutical ingredient (API) led to its reformulation into a self-emulsifying drug delivery system (SEDDS) of cyclosporine A in 1988, and it was marketed as Neoral [4, 5]. In 1995, Bristol-Myers Squibb introduced a thixotropic, sustainedrelease formulation (ca ...
... variability in delivering the active pharmaceutical ingredient (API) led to its reformulation into a self-emulsifying drug delivery system (SEDDS) of cyclosporine A in 1988, and it was marketed as Neoral [4, 5]. In 1995, Bristol-Myers Squibb introduced a thixotropic, sustainedrelease formulation (ca ...
Word 74KB
... acceptable to clinicians and consumers. The PBAC considered it may be more appropriate for a broader group of individuals to have access to Truvada as PrEP, for example all individuals for whom clinician and consumer judge the potential benefit to outweigh the risk. The PBAC noted that in order to m ...
... acceptable to clinicians and consumers. The PBAC considered it may be more appropriate for a broader group of individuals to have access to Truvada as PrEP, for example all individuals for whom clinician and consumer judge the potential benefit to outweigh the risk. The PBAC noted that in order to m ...
Using Dow Excipients for Controlled Release of
... The number that follows the chemistry designation identifies the viscosity of that product in millipascal-seconds (mPa·s), measured at 2% concentration in water at 20°C.† In designating viscosity, the letter “C” is frequently used to represent a multiplier of 100, and the letter “M” is used to repre ...
... The number that follows the chemistry designation identifies the viscosity of that product in millipascal-seconds (mPa·s), measured at 2% concentration in water at 20°C.† In designating viscosity, the letter “C” is frequently used to represent a multiplier of 100, and the letter “M” is used to repre ...
File
... or cohesive (non-free-flowing). Flow properties are significantly affected by changes in particle size, density, shape, electrostatic charge, and adsorbed moisture, which may arise from processing or formulation. Preformulation, powder flow should be determined for the improvement of pharmaceutica ...
... or cohesive (non-free-flowing). Flow properties are significantly affected by changes in particle size, density, shape, electrostatic charge, and adsorbed moisture, which may arise from processing or formulation. Preformulation, powder flow should be determined for the improvement of pharmaceutica ...
Disintegration of Tablets and Capsules Measured by Isothermal
... Tablets are solid dosage forms containing one or more active ingredients. They are obtained by single or multiple compression (in certain cases they are moulded) and may be uncoated or coated. They are usually intended for oral administration, but preparations for alternative applications, such as i ...
... Tablets are solid dosage forms containing one or more active ingredients. They are obtained by single or multiple compression (in certain cases they are moulded) and may be uncoated or coated. They are usually intended for oral administration, but preparations for alternative applications, such as i ...
Zyrtec®
... have shown no measurable affinity for receptors other than H1-receptors. Ex vivo experiments in mice have shown that systemically administered cetirizine does not significantly occupy the cerebral H1-receptors. In addition to its anti-H1 effect, cetirizine was shown to display anti-allergic activiti ...
... have shown no measurable affinity for receptors other than H1-receptors. Ex vivo experiments in mice have shown that systemically administered cetirizine does not significantly occupy the cerebral H1-receptors. In addition to its anti-H1 effect, cetirizine was shown to display anti-allergic activiti ...
2. qualitative and quantitative composition
... Polystyrene sulfonate (Kayexalate): Caution is advised when used concomitantly with polystyrene sulfonate (Kayexalate) due to the potential risks of reduced effectiveness of the resin in binding potassium, of metabolic alkalosis in patients with renal failure (reported with aluminium hydroxide and m ...
... Polystyrene sulfonate (Kayexalate): Caution is advised when used concomitantly with polystyrene sulfonate (Kayexalate) due to the potential risks of reduced effectiveness of the resin in binding potassium, of metabolic alkalosis in patients with renal failure (reported with aluminium hydroxide and m ...
Syeda Bushra Yunus
... A simple, accurate, precise and sensitive Spectrophotometric method was developed for the estimation of Clopidogrel bisulphate in pure and tablet dosage forms. The estimation of Clopidogrel bisulphate was carried out at maximum absorbance of 220 nm. The method was found to be linear and obeys Beer’s ...
... A simple, accurate, precise and sensitive Spectrophotometric method was developed for the estimation of Clopidogrel bisulphate in pure and tablet dosage forms. The estimation of Clopidogrel bisulphate was carried out at maximum absorbance of 220 nm. The method was found to be linear and obeys Beer’s ...
Tablet (pharmacy)
A tablet is a pharmaceutical dosage form. Tablets may be defined as the solid unit dosage form of medicament or medicaments with or without suitable diluents and prepared either by molding or by compression. It comprises a mixture of active substances and excipients, usually in powder form, pressed or compacted from a powder into a solid dose. The excipients can include diluents, binders or granulating agents, glidants (flow aids) and lubricants to ensure efficient tabletting; disintegrants to promote tablet break-up in the digestive tract; sweeteners or flavours to enhance taste; and pigments to make the tablets visually attractive. A polymer coating is often applied to make the tablet smoother and easier to swallow, to control the release rate of the active ingredient, to make it more resistant to the environment (extending its shelf life), or to enhance the tablet's appearance.The compressed tablet is the most popular dosage form in use today. About two-thirds of all prescriptions are dispensed as solid dosage forms, and half of these are compressed tablets. A tablet can be formulated to deliver an accurate dosage to a specific site; it is usually taken orally, but can be administered sublingually, buccally, rectally or intravaginally. The tablet is just one of the many forms that an oral drug can take such as syrups, elixirs, suspensions, and emulsions. Medicinal tablets were originally made in the shape of a disk of whatever color their components determined, but are now made in many shapes and colors to help distinguish different medicines. Tablets are often stamped with symbols, letters, and numbers, which enable them to be identified. Sizes of tablets to be swallowed range from a few millimeters to about a centimeter.